Skip to main content
Atrás
Watch Compare

Monopar Therapeutics

Calidad de datos: 100%
MNPR
Nasdaq Manufacturing Chemicals
$57.28
▼ $0.75 (-1.29%)
Cap. Mercado: 385.07 M
Precio
$57.28
Cap. Mercado
385.07 M
Rango del Día
$55.90 — $58.39
Rango de 52 Semanas
$28.40 — $105.00
Volumen
315,592
Apertura $57.33
Promedio 50D / 200D
$58.30
1.76% below
Promedio 50D / 200D
$61.03
6.15% below

Quick Summary

Puntos Clave

Negative free cash flow of -12.20 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-14.16%
Above sector avg (-51.02%)
ROIC-13.61%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio56.10
Interest CoverageN/A

Valoración

PE (TTM)
-28.07
Below sector avg (-1.98)
P/B Ratio2.72
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -28.1 -2.0
P/B 2.7 5.1
ROE % -14.2 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -13.72 M
ROE -14.16% ROA -13.85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.20 M
ROIC -13.61% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 56.10
Interest Coverage N/A Asset Turnover 0.00
Working Capital 141.52 M Tangible Book Value 141.56 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -28.07 Forward P/E N/A
P/B Ratio 2.72 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.17%
Market Cap 385.07 M Enterprise Value 257.39 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share -1.82 OCF / Share -1.82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88.95%
SBC-Adj. FCF -16.13 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 — —
Net Income -13.72 M -15.59 M -8.40 M -10.52 M -9.10 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -16.70 M -16.16 M -8.83 M -10.54 M -9.13 M
EBITDA — — — — —
R&D Expenses 9.90 M 13.01 M 5.60 M 7.59 M 6.49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — 429,039.0 21,239.0 24,024.0
Income Tax 800.0 800.0 800.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 140.72 M 60.29 M 7.35 M 13.23 M 20.52 M
Total Liabilities 2.89 M 5.25 M 1.76 M 3.14 M 1.58 M
Shareholders' Equity 137.83 M 55.04 M 5.59 M 10.09 M 18.94 M
Total Debt — — — — —
Cash & Equivalents 61.83 M 45.82 M 7.27 M 8.19 M 20.30 M
Current Assets 140.46 M 60.29 M 7.33 M 13.17 M 20.52 M
Current Liabilities 2.74 M — 1.76 M 3.13 M —